ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.

Elena Georgiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.